<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="acb6e57b-af44-432f-a4de-a293a2e20121"><labelDrug name="CALAN SR"><Normalization/></labelDrug><generic name="verapamil hydrochloride"/><sentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.1" text="CALAN SR (verapamil hydrochloride) tablet, film coated, extended release" type="negative"><entity charOffset="0:8" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.1.e.0" text="calan sr" type="Biomedical_Entity"><Normalization><mmtx cui="C0719083" phraseText="CALAN SR (verapamil hydrochloride" preferredWord="Calan SR" semType="phsu, orch"/><RxNorm RxCui="203490"/></Normalization></entity><entity charOffset="10:33" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.1.e.1" text="verapamil hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0700468" phraseText="CALAN SR (verapamil hydrochloride" preferredWord="Verapamil hydrochloride" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.1.e.0" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.1.e.1"/></sentence><sentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2" text="CALAN SR (verapamil hydrochloride) is a calcium ion influx inhibitor (slow-channel blocker or calcium ion antagonist)." type="negative"><entity charOffset="0:8" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.0" text="calan sr" type="Biomedical_Entity"><Normalization><mmtx cui="C0719083" phraseText="CALAN SR (verapamil hydrochloride" preferredWord="Calan SR" semType="phsu, orch"/><RxNorm RxCui="203490"/></Normalization></entity><entity charOffset="94:116" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.1" text="calcium antagonist" type="Biomedical_Entity"><Normalization><mmtx cui="C0006684" phraseText="calcium ion antagonist" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="10:33" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.2" text="verapamil hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0700468" phraseText="CALAN SR (verapamil hydrochloride" preferredWord="Verapamil hydrochloride" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="40:51" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.3" text="calcium ion" type="Biomedical_Entity"><Normalization><mmtx cui="C0596235" phraseText="a calcium ion influx inhibitor" preferredWord="Calcium ion" semType="phsu, elii"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="75:90" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.4" text="channel blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0870261" phraseText="(slow-channel blocker" preferredWord="channel blockers" semType="phsu"/><RxNorm RxCui="20793"/></Normalization></entity><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.0" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.1"/><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.0" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.2"/><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.0" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.3"/><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.0" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.4"/><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.2" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.1"/><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.3" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.1"/><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.4" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.1"/><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.2" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.3"/><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.2" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.4"/><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.3" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.2.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.15" lineNumber="22" text="Verapamil should be avoided in patients with severe left ventricular dysfunction (eg, ejection fraction less than 30%) or moderate to severe symptoms of cardiac failure and in patients with any degree of ventricular dysfunction if they are receiving a beta-adrenergic blocker (see PRECAUTIONS, Drug interactions). " type="regular"><entity charOffset="20:27" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.15.e.0" text="avoided" type="Caution_Interaction"/><entity charOffset="20:27" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.15.e.2" text="avoided" type="SPAN"/><entity charOffset="0:9" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.15.e.3" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="204:227" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.15.e.4" text="ventricular dysfunction" type="SPAN"/><entity charOffset="252:275" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.15.e.5" text="beta-adrenergic blocker" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="a beta-adrenergic blocker" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><mmtx cui="C3536830" phraseText="a beta-adrenergic blocker" preferredWord="beta-Adrenergic Blocker [EPC]" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.15.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.15.e.0"><relations><relation type="hasContext"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.15.e.4"/></relation><relation type="hasSeverity"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.15.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.15.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.15.e.5"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.15.e.4" ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.15.e.3" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.15.e.5" severity="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.15.e.2" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.15.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.16" text="Patients with milder ventricular dysfunction should, if possible, be controlled with optimum doses of digitalis and/or diuretics before verapamil treatment. " type="negative"><entity charOffset="102:111" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.16.e.0" text="digitalis" type="Biomedical_Entity"><Normalization><mmtx cui="C0304520" phraseText="controlled with optimum doses of digitalis" preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><entity charOffset="136:145" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.16.e.1" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="diuretics before verapamil treatment." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="119:128" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.16.e.2" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretics before verapamil treatment." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.16.e.0" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.16.e.1"/><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.16.e.0" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.16.e.2"/><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.16.e.2" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.16.e.1"/></sentence><sentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.30" text="Some patients with paroxysmal and/or chronic atrial fibrillation or atrial flutter and a coexisting accessory AV pathway have developed increased antegrade conduction across the accessory pathway bypassing the AV node, producing a very rapid ventricular response or ventricular fibrillation after receiving intravenous verapamil (or digitalis). " type="negative"><entity charOffset="333:342" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.30.e.0" text="digitalis" type="Biomedical_Entity"><Normalization><mmtx cui="C0304520" phraseText="digitalis" preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><entity charOffset="319:328" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.30.e.1" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="receiving intravenous verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.30.e.1" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.30.e.0"/></sentence><sentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.40" text="In 120 patients with hypertrophic cardiomyopathy (most of them refractory or intolerant to propranolol) who received therapy with verapamil at doses up to 720 mg/day, a variety of serious adverse effects were seen. " type="negative"><entity charOffset="130:139" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.40.e.0" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="therapy with verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="91:102" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.40.e.1" text="propranolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0033497" phraseText="intolerant to propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.40.e.1" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.40.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.45" lineNumber="42" text="Concomitant administration of quinidine (see PRECAUTIONS, Drug interactions) preceded the severe hypotension in 3 of the 8 patients (2 of whom developed pulmonary edema). " type="irregular"><entity charOffset="30:39" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.45.e.0" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="Concomitant administration of quinidine" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="90:108" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.45.e.1" text="severe hypotension" type="Specific_Interaction"/><entity charOffset="121:131" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.45.e.3" text="8 patients" type="SPAN"/><entity charOffset="153:168" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.45.e.4" text="pulmonary edema" type="Specific_Interaction"><Normalization><mmtx cui="C0034063" phraseText="pulmonary edema" preferredWord="Pulmonary Edema" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.45.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.45.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.45.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.40" text="In 120 patients with hypertrophic cardiomyopathy (most of them refractory or intolerant to propranolol) who received therapy with verapamil at doses up to 720 mg/day, a variety of serious adverse effects were seen. "><entity charOffset="130:139" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.40.e.0" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="therapy with verapamil" preferredWord="Verapamil" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.41" text="Three patients died in pulmonary edema; "/><middleSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.42" text="all had severe left ventricular outflow obstruction and a past history of left ventricular dysfunction. "/><middleSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.43" text="Eight other patients had pulmonary edema and/or severe hypotension; "/><middleSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.44" text="abnormally high (greater than 20 mm Hg) pulmonary wedge pressure and a marked left ventricular outflow obstruction were present in most of these patients. "/></relation><relation type="hasEvidence"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.45.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.45.ddi.2"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.45.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.45.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.40" text="In 120 patients with hypertrophic cardiomyopathy (most of them refractory or intolerant to propranolol) who received therapy with verapamil at doses up to 720 mg/day, a variety of serious adverse effects were seen. "><entity charOffset="130:139" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.40.e.0" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="therapy with verapamil" preferredWord="Verapamil" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.41" text="Three patients died in pulmonary edema; "/><middleSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.42" text="all had severe left ventricular outflow obstruction and a past history of left ventricular dysfunction. "/><middleSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.43" text="Eight other patients had pulmonary edema and/or severe hypotension; "/><middleSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.44" text="abnormally high (greater than 20 mm Hg) pulmonary wedge pressure and a marked left ventricular outflow obstruction were present in most of these patients. "/></relation><relation type="hasEvidence"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.45.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.45.e.0"/></sentence><sentence biomedicalEntities="3" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.57" lineNumber="54" text="It has been reported that verapamil decreases neuromuscular transmission in patients with Duchenne's muscular dystrophy, and that verapamil prolongs recovery from the neuromuscular blocking agent vecuronium. " type="regular"><entity charOffset="130:139" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.57.e.0" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="that verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="167:195" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.57.e.1" text="neuromuscular blocking agent" type="Drug_Class"><Normalization><mmtx cui="C0027866" phraseText="recovery from the neuromuscular blocking agent vecuronium." preferredWord="Neuromuscular Blocking Agents" semType="phsu"/><RxNorm RxCui="1036249"/></Normalization></entity><entity charOffset="196:206" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.57.e.2" text="vecuronium" type="Drug"><Normalization><mmtx cui="C0242531" phraseText="recovery from the neuromuscular blocking agent vecuronium." preferredWord="Vecuronium" semType="strd, phsu"/><RxNorm RxCui="71535"/></Normalization></entity><entity charOffset="140:157" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.57.e.4" text="prolongs recovery" type="Increase_Interaction"/><drugClassMembership drug="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.57.e.2" drugClass="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.57.e.1"/><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.57.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.57.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.57.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.57.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.57.e.0" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.57.e.2" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.57.e.4" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.66" lineNumber="64" text="Concomitant therapy with beta-adrenergic blockers and verapamil may result in additive negative effects on heart rate, atrioventricular conduction and/or cardiac contractility. " type="regular"><entity charOffset="25:49" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.66.e.0" text="beta-adrenergic blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="Concomitant therapy with beta-adrenergic blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><entity charOffset="54:63" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.66.e.1" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="64:103" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.66.e.2" text="may result in additive negative effects" type="Caution_Interaction"/><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.66.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.66.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.66.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.66.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.66.e.0" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.66.e.1" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.66.e.2" type="Caution_Interaction"/></sentence><sentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.67" text="The combination of sustained-release verapamil and beta-adrenergic blocking agents has not been studied. " type="negative"><entity charOffset="51:82" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.67.e.0" text="beta-adrenergic blocking agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta-adrenergic blocking agents" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><entity charOffset="37:46" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.67.e.1" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="The combination of sustained-release verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.67.e.1" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.67.e.0"/></sentence><sentence biomedicalEntities="0" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.68" lineNumber="64" text="However, there have been reports of excessive bradycardia and AV block, including complete heart block, when the combination has been used for the treatment of hypertension. " type="irregular"><entity charOffset="36:57" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.68.e.0" text="excessive bradycardia" type="Specific_Interaction"/><entity charOffset="62:70" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.68.e.2" text="AV block" type="Specific_Interaction"><Normalization><mmtx cui="C0004245" phraseText="AV block," preferredWord="Atrioventricular Block" semType="dsyn"/></Normalization></entity><entity charOffset="82:102" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.68.e.4" text="complete heart block" type="Specific_Interaction"><Normalization><mmtx cui="C0151517" phraseText="complete heart block," preferredWord="Complete atrioventricular block" semType="dsyn"/></Normalization></entity><entity charOffset="160:172" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.68.e.6" text="hypertension" type="SPAN"><Normalization><mmtx cui="C0020538" phraseText="used for the treatment of hypertension." preferredWord="Hypertensive disease" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.68.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.68.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.67" text="The combination of sustained-release verapamil and beta-adrenergic blocking agents has not been studied. "><entity charOffset="19:46" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.67.e.0" text="sustained-release verapamil" type="Drug"><Normalization><mmtx cui="C2732140" phraseText="The combination of sustained-release verapamil" preferredWord="Sustain" semType="phsu, orch"/><mmtx cui="C0042523" phraseText="The combination of sustained-release verapamil" preferredWord="Verapamil" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasContext"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.68.e.6"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.67" text="The combination of sustained-release verapamil and beta-adrenergic blocking agents has not been studied. "><entity charOffset="51:82" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.67.e.1" text="beta-adrenergic blocking agents" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta-adrenergic blocking agents" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.68.ddi.2"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.68.e.2"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.67" text="The combination of sustained-release verapamil and beta-adrenergic blocking agents has not been studied. "><entity charOffset="19:46" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.67.e.0" text="sustained-release verapamil" type="Drug"><Normalization><mmtx cui="C2732140" phraseText="The combination of sustained-release verapamil" preferredWord="Sustain" semType="phsu, orch"/><mmtx cui="C0042523" phraseText="The combination of sustained-release verapamil" preferredWord="Verapamil" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasContext"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.68.e.6"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.67" text="The combination of sustained-release verapamil and beta-adrenergic blocking agents has not been studied. "><entity charOffset="51:82" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.67.e.1" text="beta-adrenergic blocking agents" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta-adrenergic blocking agents" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.68.ddi.3"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.68.e.4"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.67" text="The combination of sustained-release verapamil and beta-adrenergic blocking agents has not been studied. "><entity charOffset="19:46" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.67.e.0" text="sustained-release verapamil" type="Drug"><Normalization><mmtx cui="C2732140" phraseText="The combination of sustained-release verapamil" preferredWord="Sustain" semType="phsu, orch"/><mmtx cui="C0042523" phraseText="The combination of sustained-release verapamil" preferredWord="Verapamil" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasContext"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.68.e.6"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.67" text="The combination of sustained-release verapamil and beta-adrenergic blocking agents has not been studied. "><entity charOffset="51:82" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.67.e.1" text="beta-adrenergic blocking agents" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta-adrenergic blocking agents" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="0" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.70" lineNumber="64" text="The combination should be used only with caution and close monitoring." type="irregular"><entity charOffset="41:48" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.70.e.0" text="caution" type="Caution_Interaction"/><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.70.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.70.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.67" text="The combination of sustained-release verapamil and beta-adrenergic blocking agents has not been studied. "><entity charOffset="19:46" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.67.e.0" text="sustained-release verapamil" type="Drug"><Normalization><mmtx cui="C2732140" phraseText="The combination of sustained-release verapamil" preferredWord="Sustain" semType="phsu, orch"/><mmtx cui="C0042523" phraseText="The combination of sustained-release verapamil" preferredWord="Verapamil" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.68" text="However, there have been reports of excessive bradycardia and AV block, including complete heart block, when the combination has been used for the treatment of hypertension. "/><middleSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.69" text="For hypertensive patients, the risks of combined therapy may outweigh the potential benefits. "/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.67" text="The combination of sustained-release verapamil and beta-adrenergic blocking agents has not been studied. "><entity charOffset="51:82" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.67.e.1" text="beta-adrenergic blocking agents" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta-adrenergic blocking agents" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.68" text="However, there have been reports of excessive bradycardia and AV block, including complete heart block, when the combination has been used for the treatment of hypertension. "/><middleSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.69" text="For hypertensive patients, the risks of combined therapy may outweigh the potential benefits. "/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="3" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.71" lineNumber="66" text="Asymptomatic bradycardia (36 beats/min) with a wandering atrial pacemaker has been observed in a patient receiving concomitant timolol (a beta-adrenergic blocker) eyedrops and oral verapamil." type="regular"><entity charOffset="95:104" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.71.e.0" text="a patient" type="SPAN"/><entity charOffset="127:134|163:171" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.71.e.1" text="timolol eyedrops" type="Drug"><Normalization><mmtx cui="C0040233" phraseText="concomitant timolol" preferredWord="Timolol" semType="phsu, orch"/><mmtx cui="C0001645" phraseText="(a beta-adrenergic blocker" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><mmtx cui="C3536830" phraseText="(a beta-adrenergic blocker" preferredWord="beta-Adrenergic Blocker [EPC]" semType="phsu"/><RxNorm RxCui="42933"/></Normalization></entity><entity charOffset="138:161" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.71.e.2" text="beta-adrenergic blocker" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="(a beta-adrenergic blocker" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><mmtx cui="C3536830" phraseText="(a beta-adrenergic blocker" preferredWord="beta-Adrenergic Blocker [EPC]" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><entity charOffset="176:190" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.71.e.4" text="oral verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="oral verapamil." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="13:24" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.71.e.5" text="bradycardia" type="Specific_Interaction"/><entity charOffset="47:73" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.71.e.7" text="wandering atrial pacemaker" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.71.e.1" drugClass="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.71.e.2"/><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.71.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.71.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.71.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.71.e.4"/></relation><relation type="hasEvidence"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.71.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.71.ddi.2"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.71.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.71.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.71.e.4"/></relation><relation type="hasEvidence"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.71.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.71.e.1" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.71.e.4" evidence="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.71.e.0" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.71.e.5" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.72" lineNumber="68" text="A decrease in metoprolol and propranolol clearance has been observed when either drug is administered concomitantly with verapamil. " type="regular"><entity charOffset="14:24" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.72.e.0" text="metoprolol" type="Drug"><Normalization><mmtx cui="C0025859" phraseText="A decrease in metoprolol" preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="29:40" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.72.e.1" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="propranolol clearance" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="2:13|41:50" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.72.e.2" text="decrease in clearance" type="Increase_Interaction"/><entity charOffset="121:130" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.72.e.4" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="concomitantly with verapamil." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.72.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.72.e.2"><relations><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.72.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.72.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.72.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.72.e.0" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.72.e.4" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.72.e.2" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.72.e.1" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.72.e.4" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.72.e.2" type="Increase_Interaction"/></sentence><sentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.73" text="A variable effect has been seen when verapamil and atenolol were given together." type="negative"><entity charOffset="37:46" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.73.e.0" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="51:59" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.73.e.1" text="atenolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0004147" phraseText="atenolol" preferredWord="Atenolol" semType="phsu, orch"/><RxNorm RxCui="1202"/></Normalization></entity><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.73.e.0" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.73.e.1"/></sentence><sentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.75" text="Clinical use of verapamil in digitalized patients has shown the combination to be well tolerated if digoxin doses are properly adjusted. " type="negative"><entity charOffset="100:107" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.75.e.0" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="digoxin doses" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="16:25" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.75.e.1" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="Clinical use of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.75.e.1" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.75.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.76" lineNumber="72" text="However, chronic verapamil treatment can increase serum digoxin levels by 50% to 75% during the first week of therapy, and this can result in digitalis toxicity. " type="regular"><entity charOffset="17:26" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.76.e.0" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="chronic verapamil treatment" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="41:55|64:70" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.76.e.1" text="increase serum levels" type="Increase_Interaction"/><entity charOffset="56:63" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.76.e.3" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="serum digoxin levels by 50%" preferredWord="Digoxin" semType="strd, phsu, carb"/><mmtx cui="C0012265" phraseText="serum digoxin levels by 50%" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.76.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.76.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.76.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.76.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.76.e.0" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.76.e.3" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.76.e.1" type="Increase_Interaction"/></sentence><sentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.77" text="In patients with hepatic cirrhosis the influence of verapamil on digoxin kinetics is magnified. " type="negative"><entity charOffset="52:61" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.77.e.0" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="the influence of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="65:72" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.77.e.1" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="on digoxin kinetics" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.77.e.0" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.77.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.78" lineNumber="72" text="Verapamil may reduce total body clearance and extrarenal clearance of digitoxin by 27% and 29%, respectively. " type="regular"><entity charOffset="14:20|32:41" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.78.e.0" text="reduce clearance" type="Increase_Interaction"/><entity charOffset="70:79" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.78.e.2" text="digitoxin" type="Drug"><Normalization><mmtx cui="C0012258" phraseText="extrarenal clearance of digitoxin" preferredWord="Digitoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3403"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.78.e.3" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.78.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.78.e.0"><relations><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.78.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.78.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.78.e.3" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.78.e.2" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.78.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.79" lineNumber="72" text="Maintenance and digitalization doses should be reduced when verapamil is administered, and the patient should be carefully monitored to avoid over- or under-digitalization. " type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.78" Text="Verapamil may reduce total body clearance and extrarenal clearance of digitoxin by 27% and 29%, respectively. "/><anaphoraEntity charOffset="16:30" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.79.e.3" text="digitalization" type="Expression"/><antecedentEntity charOffset="70:79" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.78.e.2" text="digitoxin" type="Drug"/></anaphoraRelation><entity charOffset="123:132" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.79.e.0" text="monitored" type="Caution_Interaction"/><entity charOffset="60:69" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.79.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.79.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.79.e.0"><relations><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.79.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.79.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.79.e.3" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.79.e.2" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.79.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="6" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.83" lineNumber="76" text="Verapamil administered concomitantly with oral antihypertensive agents (eg, vasodilators, angiotensin-converting enzyme inhibitors, diuretics, beta-blockers) will usually have an additive effect on lowering blood pressure. " type="regular"><entity charOffset="0:9" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.83.e.0" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="42:70" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.83.e.1" text="oral antihypertensive agents" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="concomitantly with oral antihypertensive agents" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="76:88" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.83.e.2" text="vasodilators" type="Drug_Class"><Normalization><mmtx cui="C0042402" phraseText="vasodilators," preferredWord="Vasodilator Agents" semType="phsu"/><RxNorm RxCui="11146"/></Normalization></entity><entity charOffset="90:130" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.83.e.3" text="angiotensin-converting enzyme inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="angiotensin-converting enzyme inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="6162"/></Normalization></entity><entity charOffset="132:141" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.83.e.4" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="diuretics," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="143:156" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.83.e.5" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta-blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="198:221" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.83.e.6" text="lowering blood pressure" type="Specific_Interaction"/><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.83.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.83.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.83.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.83.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.83.e.0" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.83.e.1" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.83.e.6" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.84" lineNumber="76" text="Patients receiving these combinations should be appropriately monitored. " type="irregular"><entity charOffset="62:71" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.84.e.0" text="monitored" type="Caution_Interaction"/><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.84.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.84.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.83" text="Verapamil administered concomitantly with oral antihypertensive agents (eg, vasodilators, angiotensin-converting enzyme inhibitors, diuretics, beta-blockers) will usually have an additive effect on lowering blood pressure. "><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.83.e.1"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.83" text="Verapamil administered concomitantly with oral antihypertensive agents (eg, vasodilators, angiotensin-converting enzyme inhibitors, diuretics, beta-blockers) will usually have an additive effect on lowering blood pressure. "><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.83.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.85" lineNumber="76" text="Concomitant use of agents that attenuate alpha-adrenergic function with verapamil may result in a reduction in blood pressure that is excessive in some patients. " type="regular"><entity charOffset="19:66" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.85.e.0" text="agents that attenuate alpha-adrenergic function" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="Concomitant use of agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="126263"/></Normalization></entity><entity charOffset="72:81" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.85.e.1" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="alpha-adrenergic function with verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="98:125|134:143" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.85.e.2" text="reduction in blood pressure excessive" type="Specific_Interaction"/><entity charOffset="98:125|134:143" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.85.e.4" text="reduction in blood pressure excessive" type="SPAN"/><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.85.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.85.e.2"><relations><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.85.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.85.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.85.e.0" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.85.e.1" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.85.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.86" lineNumber="76" text="Such an effect was observed in one study following the concomitant administration of verapamil and prazosin." type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.85" Text="Concomitant use of agents that attenuate alpha-adrenergic function with verapamil may result in a reduction in blood pressure that is excessive in some patients. "/><anaphoraEntity charOffset="0:14" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.86.e.1" text="Such an effect" type="Expression"/><antecedentEntity charOffset="98:143" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.85.e.2" text="reduction in blood pressure excessive" type="Specific_Interaction"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.85" Text="Concomitant use of agents that attenuate alpha-adrenergic function with verapamil may result in a reduction in blood pressure that is excessive in some patients. "/><anaphoraEntity charOffset="0:14" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.86.e.1" text="Such an effect" type="Expression"/><antecedentEntity charOffset="98:143" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.85.e.4" text="reduction in blood pressure excessive" type="SPAN"/></anaphoraRelation><entity charOffset="85:94" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.86.e.0" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="the concomitant administration of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="31:40" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.86.e.3" text="one study" type="SPAN"/><entity charOffset="99:107" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.86.e.4" text="prazosin" type="Drug"><Normalization><mmtx cui="C0032912" phraseText="prazosin." preferredWord="Prazosin" semType="phsu, orch"/><RxNorm RxCui="8629"/></Normalization></entity><entity charOffset="0:14" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.86.e.5" text="Such an effect" type="Specific_Interaction"/><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.86.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.86.e.5"><relations><relation type="hasEvidence"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.86.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.86.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.86.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.86.e.0" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.86.e.4" evidence="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.86.e.3" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.86.e.5" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.89" lineNumber="82" text="Until data on possible interactions between verapamil and disopyramide phosphate are obtained, disopyramide should not be administered within 48 hours before or 24 hours after verapamil administration." type="regular"><entity charOffset="115:134|151:157|170:175" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.89.e.0" text="not be administered before after" type="Caution_Interaction"/><entity charOffset="95:107" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.89.e.2" text="disopyramide" type="Drug"><Normalization><mmtx cui="C0012702" phraseText="disopyramide" preferredWord="Disopyramide" semType="phsu, orch"/><RxNorm RxCui="3541"/></Normalization></entity><entity charOffset="176:185" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.89.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="24 hours after verapamil administration." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.89.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.89.e.0"><relations><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.89.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.89.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.89.e.2" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.89.e.3" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.89.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.91" lineNumber="86" text="A study in healthy volunteers showed that the concomitant administration of flecainide and verapamil may have additive effects on myocardial contractility, AV conduction, and repolarization. " type="regular"><entity charOffset="130:154" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.91.e.0" text="myocardial contractility" type="Specific_Interaction"/><entity charOffset="156:169" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.91.e.2" text="AV conduction" type="Specific_Interaction"/><entity charOffset="175:189" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.91.e.4" text="repolarization" type="Specific_Interaction"/><entity charOffset="76:86" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.91.e.6" text="flecainide" type="Drug"><Normalization><mmtx cui="C0016229" phraseText="the concomitant administration of flecainide" preferredWord="Flecainide" semType="phsu, orch"/><RxNorm RxCui="4441"/></Normalization></entity><entity charOffset="91:100" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.91.e.7" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.91.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.91.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.91.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.91.e.7"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.91.ddi.2"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.91.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.91.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.91.e.7"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.91.ddi.3"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.91.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.91.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.91.e.7"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.91.e.6" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.91.e.7" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.91.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.92" lineNumber="86" text="Concomitant therapy with flecainide and verapamil may result in additive negative inotropic effect and prolongation of atrioventricular conduction." type="regular"><entity charOffset="73:98" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.92.e.0" text="negative inotropic effect" type="Specific_Interaction"/><entity charOffset="103:146" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.92.e.2" text="prolongation of atrioventricular conduction" type="Specific_Interaction"/><entity charOffset="25:35" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.92.e.4" text="flecainide" type="Drug"><Normalization><mmtx cui="C0016229" phraseText="Concomitant therapy with flecainide" preferredWord="Flecainide" semType="phsu, orch"/><RxNorm RxCui="4441"/></Normalization></entity><entity charOffset="40:49" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.92.e.5" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.92.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.92.e.0"><relations><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.92.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.92.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.92.ddi.2"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.92.e.2"><relations><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.92.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.92.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.92.e.4" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.92.e.5" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.92.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.94" lineNumber="90" text="In a small number of patients with hypertrophic cardiomyopathy (IHSS), concomitant use of verapamil and quinidine resulted in significant hypotension. " type="regular"><entity charOffset="5:29" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.94.e.0" text="small number of patients" type="SPAN"/><entity charOffset="35:62" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.94.e.1" text="hypertrophic cardiomyopathy" type="SPAN"><Normalization><mmtx cui="C0007194" phraseText="with hypertrophic cardiomyopathy" preferredWord="Hypertrophic Cardiomyopathy" semType="dsyn"/></Normalization></entity><entity charOffset="90:99" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.94.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="concomitant use of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="104:113" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.94.e.3" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="quinidine" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="138:149" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.94.e.4" text="hypotension" type="Specific_Interaction"/><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.94.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.94.e.4"><relations><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.94.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.94.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.94.e.3"/></relation><relation type="hasEvidence"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.94.e.0"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.94.e.1" ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.94.e.2" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.94.e.3" evidence="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.94.e.0" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.94.e.4" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.95" lineNumber="90" text="Until further data are obtained, combined therapy of verapamil and quinidine in patients with hypertrophic cardiomyopathy should probably be avoided." type="regular"><entity charOffset="141:148" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.95.e.0" text="avoided" type="Caution_Interaction"/><entity charOffset="53:62" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.95.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="combined therapy of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="67:76" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.95.e.3" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="quinidine in patients" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="94:121" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.95.e.4" text="hypertrophic cardiomyopathy" type="SPAN"><Normalization><mmtx cui="C0007194" phraseText="with hypertrophic cardiomyopathy" preferredWord="Hypertrophic Cardiomyopathy" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.95.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.95.e.0"><relations><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.95.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.95.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.95.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.95.e.4" ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.95.e.2" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.95.e.3" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.95.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.96" text="The electrophysiologic effects of quinidine and verapamil on AV conduction were studied in 8 patients. " type="negative"><entity charOffset="34:43" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.96.e.0" text="quinidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0034414" phraseText="The electrophysiologic effects of quinidine" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="48:57" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.96.e.1" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="verapamil on AV conduction" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.96.e.0" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.96.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.97" lineNumber="92" text="Verapamil significantly counteracted the effects of quinidine on AV conduction. " type="regular"><entity charOffset="0:9" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.97.e.0" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil significantly" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="52:61" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.97.e.1" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="the effects of quinidine" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="65:78" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.97.e.2" text="AV conduction" type="Specific_Interaction"/><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.97.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.97.e.2"><relations><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.97.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.97.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.97.e.0" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.97.e.1" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.97.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.98" lineNumber="92" text="There has been a report of increased quinidine levels during verapamil therapy." type="regular"><entity charOffset="27:36|47:53" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.98.e.0" text="increased levels" type="Increase_Interaction"/><entity charOffset="37:46" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.98.e.2" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="a report of increased quinidine levels" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="61:70" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.98.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="during verapamil therapy." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="15:23" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.98.e.4" text="a report" type="SPAN"/><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.98.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.98.e.0"><relations><relation type="hasEvidence"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.98.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.98.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.98.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.98.e.2" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.98.e.3" evidence="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.98.e.4" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.98.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.101" lineNumber="98" text="Verapamil has been found to inhibit ethanol elimination significantly, resulting in elevated blood ethanol concentrations that may prolong the intoxicating effects of alcohol (see CLINICAL PHARMACOLOGY, Pharmacokinetics and metabolism)." type="regular"><entity charOffset="28:35|44:55" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.101.e.0" text="inhibit elimination" type="Increase_Interaction"><Normalization><mmtx cui="C0018790" phraseText="inhibit" preferredWord="Cardiac Arrest" semType="dsyn"/></Normalization></entity><entity charOffset="36:43" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.101.e.2" text="ethanol" type="Substance"><Normalization><RxNorm RxCui="448"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.101.e.3" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.101.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.101.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.101.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.101.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.101.e.3" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.101.e.2" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.101.e.0" type="Increase_Interaction"/></sentence><sentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.106" text="The interaction between cimetidine and chronically administered verapamil has not been studied. " type="negative"><entity charOffset="64:73" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.106.e.0" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="chronically administered verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="24:34" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.106.e.1" text="cimetidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0008783" phraseText="The interaction between cimetidine" preferredWord="Cimetidine" semType="phsu, orch"/><RxNorm RxCui="2541"/></Normalization></entity><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.106.e.1" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.106.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.108" lineNumber="106" text="clearance of verapamil was either reduced or unchanged." type="irregular"><entity charOffset="0:9|34:41" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.108.e.0" text="clearance reduced" type="Increase_Interaction"/><entity charOffset="13:22" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.108.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="clearance of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.108.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.108.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.106" text="The interaction between cimetidine and chronically administered verapamil has not been studied. "><entity charOffset="24:34" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.106.e.0" text="cimetidine" type="Drug"><Normalization><mmtx cui="C0008783" phraseText="The interaction between cimetidine" preferredWord="Cimetidine" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.107" text="Variable results on clearance have been obtained in acute studies of healthy volunteers; "/></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.108.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="3" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.110" lineNumber="110" text="Increased sensitivity to the effects of lithium (neurotoxicity) has been reported during concomitant verapamil-lithium therapy; " type="regular"><anaphoraRelation><anaphoraEntity charOffset="40:47" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.110.e.4" text="lithium" type="Drug"/><antecedentEntity charOffset="111-118" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.110.e.3" text="lithium" type="Drug"/></anaphoraRelation><entity charOffset="49:62" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.110.e.0" text="neurotoxicity" type="Specific_Interaction"/><entity charOffset="101:110" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.110.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="reported during concomitant verapamil-lithium therapy" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="111:118" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.110.e.3" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="reported during concomitant verapamil-lithium therapy" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="40:47" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.110.e.4" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Increased sensitivity to the effects of lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.110.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.110.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.110.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.110.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.110.e.4" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.110.e.2" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.110.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.111" lineNumber="110" text="lithium levels have been observed sometimes to increase, sometimes to decrease, and sometimes to be unchanged. " type="irregular"><entity charOffset="8:14|47:55" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.111.e.0" text="levels increase" type="Increase_Interaction"/><entity charOffset="8:14|70:78" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.111.e.2" text="levels decrease" type="Decrease_Interaction"/><entity charOffset="0:7" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.111.e.4" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="lithium levels" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.111.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.111.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.110" text="Increased sensitivity to the effects of lithium (neurotoxicity) has been reported during concomitant verapamil-lithium therapy; "><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.110.e.2"/></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.111.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.111.ddi.2"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.111.e.2"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.110" text="Increased sensitivity to the effects of lithium (neurotoxicity) has been reported during concomitant verapamil-lithium therapy; "><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.110.e.2"/></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.111.e.4"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="0" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.112" lineNumber="110" text="Patients receiving both drugs must be monitored carefully." type="irregular"><entity charOffset="38:47" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.112.e.0" text="monitored" type="Caution_Interaction"/><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.112.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.112.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.111" text="lithium levels have been observed sometimes to increase, sometimes to decrease, and sometimes to be unchanged. "><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.111.e.4"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.110" text="Increased sensitivity to the effects of lithium (neurotoxicity) has been reported during concomitant verapamil-lithium therapy; "><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.110.e.2"/></ellipsisSentence><middleSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.111" text="lithium levels have been observed sometimes to increase, sometimes to decrease, and sometimes to be unchanged. "/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.114" lineNumber="114" text="Verapamil therapy may increase carbamazepine concentrations during combined therapy. " type="regular"><entity charOffset="22:30|45:59" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.114.e.0" text="increase concentrations" type="Increase_Interaction"/><entity charOffset="0:9" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.114.e.2" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil therapy" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="31:44" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.114.e.3" text="carbamazepine" type="Drug"><Normalization><mmtx cui="C0006949" phraseText="carbamazepine concentrations during combined therapy." preferredWord="Carbamazepine" semType="phsu, orch"/><RxNorm RxCui="2002"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.114.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.114.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.114.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.114.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.114.e.2" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.114.e.3" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.114.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.117" lineNumber="118" text="Therapy with rifampin may markedly reduce oral verapamil bioavailability." type="regular"><entity charOffset="35:41|57:72" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.117.e.0" text="reduce bioavailability" type="Decrease_Interaction"/><entity charOffset="42:56" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.117.e.2" text="oral verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="oral verapamil bioavailability." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="13:21" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.117.e.3" text="rifampin" type="Drug"><Normalization><mmtx cui="C0035608" phraseText="Therapy with rifampin" preferredWord="Rifampin" semType="orch, antb"/><RxNorm RxCui="9384"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.117.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.117.e.0"><relations><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.117.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.117.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.117.e.3" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.117.e.2" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.117.e.0" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.119" lineNumber="122" text="Phenobarbital therapy may increase verapamil clearance." type="regular"><entity charOffset="26:34|45:54" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.119.e.0" text="increase clearance" type="Decrease_Interaction"/><entity charOffset="35:44" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.119.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil clearance." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="0:13" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.119.e.3" text="Phenobarbital" type="Drug"><Normalization><mmtx cui="C0031412" phraseText="Phenobarbital therapy" preferredWord="Phenobarbital" semType="phsu, orch"/><RxNorm RxCui="8134"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.119.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.119.e.0"><relations><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.119.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.119.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.119.e.3" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.119.e.2" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.119.e.0" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.121" lineNumber="126" text="Verapamil therapy may increase serum levels of cyclosporin." type="regular"><entity charOffset="22:43" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.121.e.0" text="increase serum levels" type="Increase_Interaction"/><entity charOffset="0:9" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.121.e.2" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil therapy" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="47:58" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.121.e.3" text="cyclosporin" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="serum levels of cyclosporin." preferredWord="Cyclosporine" semType="phsu, aapp"/><mmtx cui="C0010592" phraseText="serum levels of cyclosporin." preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.121.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.121.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.121.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.121.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.121.e.2" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.121.e.3" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.121.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.123" lineNumber="130" text="Verapamil may inhibit the clearance and increase the plasma levels of theophylline." type="regular"><entity charOffset="14:35" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.123.e.0" text="inhibit the clearance" type="Increase_Interaction"><Normalization><mmtx cui="C0018790" phraseText="inhibit" preferredWord="Cardiac Arrest" semType="dsyn"/></Normalization></entity><entity charOffset="40:66" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.123.e.2" text="increase the plasma levels" type="Increase_Interaction"/><entity charOffset="0:9" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.123.e.4" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="70:82" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.123.e.5" text="theophylline" type="Drug"><Normalization><mmtx cui="C0039771" phraseText="the plasma levels of theophylline." preferredWord="Theophylline" semType="bacs, phsu, orch"/><mmtx cui="C0039771" phraseText="the plasma levels of theophylline." preferredWord="Theophylline" semType="bacs, phsu, orch"/><RxNorm RxCui="10438"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.123.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.123.e.0"><relations><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.123.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.123.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.123.ddi.2"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.123.e.2"><relations><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.123.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.123.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.123.e.4" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.123.e.5" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.123.e.0" type="Increase_Interaction"/></sentence><sentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.125" text="Animal experiments have shown that inhalation anesthetics depress cardiovascular activity by decreasing the inward movement of calcium ions. " type="negative"><entity charOffset="127:139" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.125.e.0" text="calcium ions" type="Biomedical_Entity"><Normalization><mmtx cui="C0596235" phraseText="the inward movement of calcium ions." preferredWord="Calcium ion" semType="phsu, elii"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="35:57" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.125.e.1" text="inhalation anesthetics" type="Biomedical_Entity"><Normalization><mmtx cui="C0242903" phraseText="that inhalation anesthetics" preferredWord="Anesthetics, Inhalation" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.125.e.1" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.125.e.0"/></sentence><sentence biomedicalEntities="3" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.126" lineNumber="134" text="When used concomitantly, inhalation anesthetics and calcium antagonists, such as verapamil, should each be titrated carefully to avoid excessive cardiovascular depression." type="regular"><entity charOffset="107:125" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.126.e.0" text="titrated carefully" type="Caution_Interaction"/><entity charOffset="81:90" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.126.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="such as verapamil," preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="52:71" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.126.e.3" text="calcium antagonists" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="calcium antagonists," preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="25:47" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.126.e.5" text="inhalation anesthetics" type="Drug_Class"><Normalization><mmtx cui="C0242903" phraseText="inhalation anesthetics" preferredWord="Anesthetics, Inhalation" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><drugClassMembership drug="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.126.e.2" drugClass="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.126.e.3"/><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.126.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.126.e.0"><relations><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.126.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.126.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.126.e.5" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.126.e.2" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.126.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.128" lineNumber="138" text="Clinical data and animal studies suggest that verapamil may potentiate the activity of neuromuscular blocking agents (curare-like and depolarizing). " type="regular"><entity charOffset="60:70" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.128.e.0" text="potentiate" type="Increase_Interaction"/><entity charOffset="18:32" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.128.e.2" text="animal studies" type="SPAN"/><entity charOffset="46:55" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.128.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="that verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="87:147" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.128.e.4" text="neuromuscular blocking agents (curare-like and depolarizing)" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="the activity of neuromuscular blocking agents" preferredWord="Pharmacologic Substance" semType="phsu"/><mmtx cui="C0010463" phraseText="(curare-" preferredWord="Curare" semType="phsu, orch, hops"/><RxNorm RxCui="1036249"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.128.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.128.e.0"><relations><relation type="hasEvidence"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.128.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.128.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.128.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.128.e.3" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.128.e.4" evidence="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.128.e.2" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.128.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.129" lineNumber="138" text="It may be necessary to decrease the dose of verapamil and/or the dose of the neuromuscular blocking agent when the drugs are used concomitantly." type="regular"><entity charOffset="23:40" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.129.e.0" text="decrease the dose" type="Caution_Interaction"/><entity charOffset="44:53" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.129.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="the dose of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="77:105" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.129.e.3" text="neuromuscular blocking agent" type="Drug_Class"><Normalization><mmtx cui="C0027866" phraseText="the dose of the neuromuscular blocking agent" preferredWord="Neuromuscular Blocking Agents" semType="phsu"/><RxNorm RxCui="1036249"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.129.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.129.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.129.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.129.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.129.e.2" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.129.e.3" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.129.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.131" lineNumber="142" text="Hypotension and bradyarrhythmias have been observed in patients receiving concurrent telithromycin, an antibiotic in the ketolide class." type="irregular"><entity charOffset="0:11" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.131.e.0" text="Hypotension" type="Specific_Interaction"/><entity charOffset="16:32" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.131.e.2" text="bradyarrhythmias" type="Specific_Interaction"><Normalization><mmtx cui="C0079035" phraseText="bradyarrhythmias" preferredWord="Bradyarrhythmia (disorder)" semType="dsyn"/></Normalization></entity><entity charOffset="85:98" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.131.e.4" text="telithromycin" type="Drug"><Normalization><mmtx cui="C0907410" phraseText="concurrent telithromycin," preferredWord="telithromycin" semType="orch, antb"/><RxNorm RxCui="274786"/></Normalization></entity><entity charOffset="103:113" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.131.e.5" text="antibiotic" type="Drug_Class"><Normalization><mmtx cui="C0003232" phraseText="an antibiotic in the ketolide class." preferredWord="Antibiotics" semType="antb"/><RxNorm RxCui="901"/></Normalization></entity><entity charOffset="121:129" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.131.e.6" text="ketolide" type="Drug_Class"><Normalization><mmtx cui="C1449860" phraseText="an antibiotic in the ketolide class." preferredWord="Ketolides" semType="phsu, orch"/><RxNorm RxCui="470117"/></Normalization></entity><drugClassMembership drug="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.131.e.4" drugClass="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.131.e.6"/><classClassMembership drugClass="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.131.e.6"/><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.131.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.131.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.131.e.4"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.129" text="It may be necessary to decrease the dose of verapamil and/or the dose of the neuromuscular blocking agent when the drugs are used concomitantly."><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.129.e.2"/></ellipsisSentence><middleSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.130" text="Telithromycin"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.131.ddi.2"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.131.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.131.e.4"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.129" text="It may be necessary to decrease the dose of verapamil and/or the dose of the neuromuscular blocking agent when the drugs are used concomitantly."><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.129.e.2"/></ellipsisSentence><middleSentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.130" text="Telithromycin"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.131.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.133" lineNumber="146" text="Sinus bradycardia resulting in hospitalization and pacemaker insertion has been reported in association with the use of clonidine concurrently with verapamil. " type="regular"><entity charOffset="0:17" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.133.e.0" text="Sinus bradycardia" type="Specific_Interaction"/><entity charOffset="120:129" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.133.e.2" text="clonidine" type="Drug"><Normalization><mmtx cui="C0009014" phraseText="of clonidine concurrently" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="148:157" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.133.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="with verapamil." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.133.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.133.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.133.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.133.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.133.e.2" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.133.e.3" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.133.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.134" lineNumber="146" text="Monitor heart rate in patients receiving concomitant verapamil and clonidine." type="regular"><entity charOffset="0:7" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.134.e.0" text="Monitor" type="Caution_Interaction"/><entity charOffset="53:62" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.134.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="concomitant verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="67:76" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.134.e.3" text="clonidine" type="Drug"><Normalization><mmtx cui="C0009014" phraseText="clonidine." preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><drugInteraction id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.134.ddi.1"><interaction trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.134.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.134.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.134.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.134.e.2" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.134.e.3" trigger="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.134.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.151" text="Such adverse experiences have not been reported in the literature, despite a long history of use of verapamil in Europe in the treatment of cardiac side effects of beta-adrenergic agonist agents used to treat premature labor." type="negative"><entity charOffset="164:187" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.151.e.0" text="beta-adrenergic agonist" type="Biomedical_Entity"><Normalization><mmtx cui="C3536829" phraseText="of beta-adrenergic agonist agents" preferredWord="beta-Adrenergic Agonist [EPC]" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><entity charOffset="100:109" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.151.e.1" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.151.e.1" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.151.e.0"/></sentence><sentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.163" text="Initiate therapy with 180 mg of sustained-release verapamil HCl, CALAN SR, given in the morning. " type="negative"><entity charOffset="65:73" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.163.e.0" text="calan sr" type="Biomedical_Entity"><Normalization><mmtx cui="C0719083" phraseText="CALAN SR," preferredWord="Calan SR" semType="phsu, orch"/><RxNorm RxCui="203490"/></Normalization></entity><entity charOffset="50:63" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.163.e.1" text="verapamil hcl" type="Biomedical_Entity"><Normalization><mmtx cui="C0700468" phraseText="therapy with 180 mg of sustained-release verapamil HCl," preferredWord="Verapamil hydrochloride" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.163.e.1" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.163.e.0"/></sentence><sentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.166" text="The antihypertensive effects of CALAN SR are evident within the first week of therapy." type="negative"><entity charOffset="32:40" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.166.e.0" text="calan sr" type="Biomedical_Entity"><Normalization><mmtx cui="C0719083" phraseText="The antihypertensive effects of CALAN SR" preferredWord="Calan SR" semType="phsu, orch"/><RxNorm RxCui="203490"/></Normalization></entity><entity charOffset="4:20" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.166.e.1" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="The antihypertensive effects of CALAN SR" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.166.e.1" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.166.e.0"/></sentence><sentence id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.176" text="When switching from immediate-release CALAN to CALAN SR, the total daily dose in milligrams may remain the same." type="negative"><entity charOffset="47:55" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.176.e.0" text="calan sr" type="Biomedical_Entity"><Normalization><mmtx cui="C0719083" phraseText="to CALAN SR," preferredWord="Calan SR" semType="phsu, orch"/><RxNorm RxCui="203490"/></Normalization></entity><entity charOffset="38:43" id="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.176.e.1" text="calan" type="Biomedical_Entity"><Normalization><mmtx cui="C0700935" phraseText="switching from immediate-release CALAN" preferredWord="Calan" semType="phsu, orch"/><RxNorm RxCui="203490"/></Normalization></entity><pair ddi="false" e1="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.176.e.1" e2="Dailymed.acb6e57b-af44-432f-a4de-a293a2e20121.s.176.e.0"/></sentence><positiveExamples number="33"/><negativeExamples number="27"/></document>